United Therapeutics UTHR
NASDAQ UTHR
$541.70 -29.68 (-5.19%)
At close: Oct 2, 2026 · 4:00 PM EDT

United Therapeutics (UTHR) Profit After Tax (2009 - 2026)

Updated

United Therapeutics (UTHR) posted Profit After Tax of $333 million for Q2 2026, up 7.6% from $309.5 million a year earlier and up 21.1% from the prior quarter.

Analysis

United Therapeutics (UTHR) Profit After Tax (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Profit After Tax at United Therapeutics was $1.31 billion, up 5.5% year-over-year; for FY2025, it was $1.33 billion, up 11.7% from FY2024.

  • Annual Profit After Tax has increased for four consecutive years, with a five-year compound annual growth rate of 21.0% (FY2020 to FY2025).
  • In prior years, United Therapeutics' Profit After Tax was $1.2 billion in FY2024 (+21.4%), $984.8 million in FY2023 (+35.4%), $727.3 million in FY2022 (+52.9%) and $475.8 million in FY2021 (-7.6%).
  • Quarterly Profit After Tax has run from a low of $112.2 million in Q4 2021 to a high of $364.3 million in Q4 2025 over five years.
  • On a year-over-year basis, Profit After Tax increased in seven of the last eight quarters, with growth averaging 11.8%.
  • The strongest year-over-year quarter for Profit After Tax in the past five years was Q1 2022, with growth of 747.7%; the weakest was Q2 2022, with a decline of 32.8%.
  • According to Business Quant data, Profit After Tax for the three prior quarters was $274.9 million (Q1 2026), $364.3 million (Q4 2025) and $338.7 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 5.53 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.62 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 5.28 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 3.09 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -10.50 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -246.00 Mn
10 United Therapeutics 24.38 Bn 13.88 Bn 683.80 Mn 333.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 333.00 Mn
Mar 31, 2026 274.90 Mn
Dec 31, 2025 364.30 Mn
Sep 30, 2025 338.70 Mn
Jun 30, 2025 309.50 Mn
Mar 31, 2025 322.20 Mn
Dec 31, 2024 301.30 Mn
Sep 30, 2024 309.10 Mn
Jun 30, 2024 278.10 Mn
Mar 31, 2024 306.60 Mn
Dec 31, 2023 217.10 Mn
Sep 30, 2023 267.60 Mn
Jun 30, 2023 259.20 Mn
Mar 31, 2023 240.90 Mn
Dec 31, 2022 132.10 Mn
Sep 30, 2022 239.30 Mn
Jun 30, 2022 116.00 Mn
Mar 31, 2022 239.90 Mn
Dec 31, 2021 112.20 Mn
Sep 30, 2021 162.70 Mn
API Access

United Therapeutics Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=UTHR&period=max&api_key=YOUR_API_KEY